Diabetes technology

Enhancing Type 1 Diabetes Immunological Risk Prediction with Continuous Glucose Monitoring and Genetic Profiling

Diabetes Technol TherPublished Diagnostic accuracy study

Authors' conclusion

A machine learning approach combining a 1-week CGM home test and T1D GRS reliably assesses T1D immunological risk, enabling early intervention.

Study context

Population
Autoantibodies (AB)-positive healthy relatives of people with T1D; mean age 22.1 ± 11.1 years, HbA1c 5.3 ± 0.3%, BMI 24.1 ± 5.8 kg/m²; 1 week of continuous glucose monitoring (CGM) with three standardized liquid mixed meals
Participants
39 relatives
Comparison
Support vector machine (SVM) classifier with 2 recursive feature elimination (RFE)-selected features (T1D genetic risk scores (GRS) and incremental AUC) vs all features, classifying 1 vs ≥2 AB
  • 1 ABn = 18reference
  • ≥2 ABn = 21
Outcome
Classification of 1 vs ≥2 AB by AUC-ROC and AUC-PR
Methodological detailsNational Institutes of Health's (NIH) TrialNet ancillary study, linear SVM with recursive feature elimination, fivefold cross-validation
  • NIH TrialNet ancillary study
  • Linear SVM with recursive feature elimination
  • Fivefold cross-validation

Performance

As reported in the abstract

Classification of 1 vs ≥2 AB

SVM with 2 RFE-selected features (T1D GRS and incremental AUC): AUC-ROC

0.93

95% CI 0.83–1.00

SVM with 2 RFE-selected features (T1D GRS and incremental AUC): AUC-PR

0.89

95% CI 0.71–0.99

SVM with all features: AUC-ROC

0.80

95% CI 0.46–1.00

SVM with all features: AUC-PR

0.82

95% CI 0.71–0.93

Further findings

OutcomeP value
Differences between AB groups in post-SLMM % time glucose >180 mg/dL and GRSBetween 1 AB and ≥2 AB · significant differenceP = 0.020
Differences between AB groups in post-SLMM % time glucose >180 mg/dL and GRSBetween 1 AB and ≥2 AB · significant differenceP = 0.001

Original publication

Enhancing Type 1 Diabetes Immunological Risk Prediction with Continuous Glucose Monitoring and Genetic Profiling. Diabetes Technol Ther. Published 17 December 2024. doi:10.1089/dia.2024.0496

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.